Format

Send to

Choose Destination
Ann Intern Med. 2018 Dec 4. doi: 10.7326/M18-1569. [Epub ahead of print]

Effect of Liraglutide on Cardiovascular Outcomes in Elderly Patients: A Post Hoc Analysis of a Randomized Controlled Trial.

Author information

1
Larner College of Medicine at The University of Vermont, South Burlington, Vermont (M.P.G.).
2
Institute of Life Science, Swansea University Medical School, Singleton Hospital, Swansea, United Kingdom (S.C.B.).
3
Mossakowski Medical Research Centre, Polish Academy of Sciences, Warsaw, Poland (E.F.).
4
Quirónsalud Madrid and Ruber Juan Bravo University Hospitals, Universidad Europea de Madrid, Madrid, Spain (E.J.).
5
Diabetes Center Bochum-Hattingen, St. Josef-Hospital, Ruhr-University of Bochum, Bochum, Germany (M.A.N.).
6
Florida Hospital Diabetes Institute, Florida Hospital Translational Research Institute for Metabolism and Diabetes, Orlando, Florida (R.P.).
7
Hospital de Clínicas da Universidade Federal do Paraná, Curitiba, Brazil (R.R.R.).
8
Pontifícia Universidade Católica de Campinas, Campinas, Brazil (J.F.K.).
9
Novo Nordisk A/S, Søborg, Denmark (S.R., K.T., B.J.V.).
10
Diabetes Center, University of North Carolina School of Medicine, Chapel Hill, North Carolina (J.B.B.).
PMID:
30508430
DOI:
10.7326/M18-1569

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center